*Chondroitin Sulfate (from chicken sternal cartilage)
( Flex Naturally™ does not contain added chondroitin sulfate
as it is a natural part of Biocell chicken collagen II® )
A four tablet serving of Flex Naturally™
contains 500 mg of Biocell chicken collagen type II®, a patented,
hydrolyzed and denatured low molecular weight type II collagen. By weight,
Biocell chicken collagen II® contains 60% hydrolyzed type II collagen,
20% depolymerized low molecular weight chondroitin sulfates A, B, and
C, and 10% hyaluronic acid (HA).1 It also contains
glucosamine sulfate and amino acids including l-lysine, l-proline, and
hydroxyproline promoting cartilage synthesis, synovial fluid's lubricating
qualities and production of collagen for healthy tendons, ligaments,
muscles, and bone supporting healthy joint function and comfort.
Chondroitin Sulfates and Their Role in Joint Health
Chondroitin sulfates are proteoglycans manufactured within the cartilage
matrix. They are made up of repeating derivatives of glucosamine sulfate
held together by attached sugar molecules called disaccharides with
the average length of the chain consisting of 25 to 30 repeating disaccharide
units. In order to maintain healthy production of chondroitin sulfates,
glucosamine sulfate is required. Chondroitin sulfates, along with glucosamine
sulfate, help to attract and keep water in the cartilage. Cartilage
is 80% water and is vital for keeping the cartilage flexible and shock
absorbent. If the cartilage loses too much water, it will lose it’s
shock absorbent qualities and deteriorate, forming cracks and will wear
away until eventually there is bone on bone.2 They
also inhibit destructive enzymes from breaking down healthy cartilage
and stimulate the production of collagen, gylcosaminoglycans and other
proteoglycans, which are needed to maintain healthy cartilage.3
Why Flex Naturally™ contains no
added Bovine Chondroitin Sulfate
Research with chondroitin sulfate from bovine trachea, pig, and sea
cucumber has demonstrated very little benefit in the treatment of arthritis.
That's because the chondroitin sulfate molecules are too large to pass
intact through the human digestive tract. And, if any chondroitin sulfate
molecules did manage did get into the blood stream they are still too
large to pass through the synovial membrane which surrounds the joint
capsule to be delivered to the cartilage cells. While glucosamine has
an absorption rate of 90% to 98%,4, 5 chondroitin sulfate
has been calculated to be anywhere from 0 to 13%. 6, 7
That’s because chondroitin sulfate contains a mixture of intact and
partially hydrolyzed GAGS (glycosaminoglycans) of molecular weights
ranging in size from 14,000 to over 30,000. This means chondroitin sulfate
is 50 to 300 times larger than glucosamine sulfate.
Researchers Find No Proof Chondroitin
Sulfate can be absorbed When Taken Orally
In one study researchers administered 1 gram (1,000 mg) of chondroitin
sulfate orally to human subjects. If any chondroitin sulfate was absorbed
it would be indicated by increased serum GAG (glycosaminoglycan) concentration
based on a highly sensitive indicator of intact or depolymerized GAGS.
The test demonstrated that no level of chondroitin sulfate had successfully
entered the blood stream through the digestive tract.
The results of this test led the researchers to conclude, “We
suggest that chondroprotection by orally administering chondroitin sulfate
is a biologically and pharmacologically unfounded theory.”8
After further analysis on the use of chondroitin sulfate, they concluded,”Pooled
literature on chondroitin sulfate biochemistry offers enough information
to assert that neither intact or polymerized chondroitin sulfate is
absorbed by the mammalian digestive tract. Therefore, any direct action
of orally administered chondroitin sulfate on cartilage and chondrocytes
is not possible.” 9
Natural Occurring Silica in Chondroitin Sulfate
It is interesting to note that while researchers say that chondroitin
sulfate cannot be absorbed in the digestive tract many people with arthritis
say that they benefit from it. Also, besides improving arthritic symptoms,
chondroitin sulfate has been used to treat cardiovascular disease, in
particular the removal of atherosclerotic plaque.
If
chondroitin sulfate cannot be absorbed, then how can it be beneficial?
In a publication entitled , “Trace Elements, Hair Analysis and Nutrition”,
published in 1983 under the auspices of Dr. Richard Passwater and Dr.
Elmer M. Cranton on page 217, please note what it says about chondroitin
sulfate and silicon;
Since several components of
collagen (structural polysaccharides such as chondroitin sulfate and
hyaluronic acid) contain 300 to 550 parts per million of bound silicon,
this silicon may be cross-linking these molecules, increasing their
size and stability.9 As a result, the structural
stability of such tissues as skin and arterial and stomach linings could
be improved by silicon. Arterial linings which have been stabilized
by this chemical cross-linking may be less susceptible to small injuries
that can initiate atherosclerosis. The silicon content of arteries declines
by more than half over the first forty years of age or in atherosclerosis,
even though the chondroitin sulfate content does not. 10, 11
Several studies have shown that
wherever atherosclerotic plaque is found in human arteries, there is
a considerable decrease in silicon in that artery in comparison to arteries
without plaque.'2 One study of persons over
sixty years of age determined the difference. There
was fourteen times as much silicon in disease-free arteries as in atherosclerotic
arteries.' 5 There was also a significant difference
in the amount of silicon in the blood.
Trace mineral researcher Herbert
H. Boynton points out:
"The biological mechanisms by which chondroitin sulfate and other
silicon compounds alleviate cardiovascular disease are not well known
at this time. It may be that they architecturally strengthen the walls
of the arteries and render them resistant to fatty infiltration, and
it may be that they inhibit the synthesis of an enzyme called hyaluronidase.
Hyaluronidase causes the degradation of the collagen-like, silicon containing
material which forms the interior of the blood vessels."
Mr. Boynton further emphasizes:
"There is a clear and almost
invariable relationship between the amount of silicon in the aorta (the
chief artery) and the degree of atherosclerotic deposits in the aorta:
If silicon is high, the arteries are clear. If silicon is moderate,
there is moderate atherosclerosis. If silicon is low, atherosclerosis
is severe. It would seem, then, that adding biologically available
silicon to the diet might well be helpful in preventing or alleviating
atherosclerosis. Experimental evidence confirms that this is true."
In a number of clinical trials, Dr. L.
M. Morrison and B. H. Ershoff of the Institute for Arteriosclerosis
Research at Loma Linda University have shown that chondroitin
sulfate, a natural collagenlike substance rich in silicon, has been
dramatically successful in reducing the symptoms of heart disease associated
with atherosclerosis. Similar experiments have been conducted
with equally impressive results by a team of Japanese physicians headed
by Dr. Kenjiro Izuka. Chondroitin sulfate greatly lessens the chest
pains associated with heart disease and also reduces serum cholesterol
levels. Jacqueline Loeper, a French researcher, duplicated Morrison,
Ershoff and Izuka's tests with the same results. However, she used inorganic
compounds of silicon rather than chondroitin sulfate. 16
Please Note: While
some people may say that they receive some benefit from taking chondroitin
sulfate it is more than likely because of the natural occurring silica
as well as the sulfur molecule, and not the large GAG molecules. Silica
and sulfur are used by the body to maintain healthy cell structures
such as found in the bone, cartilage, tendons, ligaments, muscles, connective
tissue, and even the synovial fluid. And if these two elements become
deficient it would have a negative impact on the structure and function
on all of these tissues resulting in poor lubrication of the joints,
and bone, joint, and soft tissue deterioration.
Chondroitin Sulfate Levels Elevated in Arthritic Joints
It’s interesting to note that chondroitin sulfate levels in synovial
tissues are usually elevated in patients with osteoarthritis.10
That being the case, trying to introduce chondroitin sulfate from an
outside source would be of no direct benefit.
Glucosamine Sulfate Important for Healthy Production of Chondroitin
Sulfate
Over 30 years of research has proven that glucosamine sulfate is vital
for stimulating the healthy production of chondroitin sulfates within
the cartilage matrix. If the amount of glucosamine sulfate is inadequate,
the production of healthy chondroitin sulfates and other critical proteoglycans
will diminish causing the deterioration of the water holding matrix.11
Since glucosamine sulfate has an 90 to 98% absorption rate
4, 5 compared to chondroitin sulfate, which is 0 to
13%, 6, 7 it makes far more sense from a biological
point to take glucosamine sulfate, MSM, and Biocell Chicken Collagen
II®, which have all proven to be far more beneficial and effective
in stimulating the natural production of healthy chondroitin sulfates
and other proteoglycans essential for maintaining healthy cartilage.
| References:
|
| 1 |
Alex Duarte,
O.D., Ph.D., The Chicken Sternal Collagen Type II Cure (1997):2,
36 |
| 2 |
Alex Duarte,
O.D., Ph.D., The Chicken Sternal Collagen Type II Cure (1997): 81 |
| 3 |
Michael Loes, M.D., Gary
Wikholm, M.D., Megan Shields, M.D., David Steinman, Arthritis the
Doctor’s Cure (1998):176-179 4 |
| 4 |
Setnikar I, et al; Pharmacokinetics
of glucosamine in man. Arzneim Forsch 43(10):1109-13, 1993 |
| 5 |
Setnikar I, et al; Pharmacokinetics
of glucosamine in the dog and man. Arzneim Forsch 36(4):729-35,
1986 |
| 6 |
A. Baci et al, “Analysis
of Gylcosaminoglycans in Human Sera after Oral Administration of
Chondroitin Sulfate,” Rheumtol Int 12 (1992):81-8 |
| 7 |
A. Conte et al, “Biochemical
and Pharmokinetic Aspects of Oral Treatment with Chondroitin Sulfate
,’ Arzneim Forsch 45 (1995) :918-925 |
| 8 |
A. Baci et al, “Analysis
of Gylcosaminoglycans in Human Sera after Oral Administration of
Chondroitin Sulfate,” Rheumtol Int 12 (1992):81-8 |
| 9 |
Baici A and Wagenhauser
FJ: Bioavailability of oral chondroitin sulfate. Rheumatology Int
13:41-43, 1993 |
| 10 |
Shinmei M, et al.;Significance
of the levels of carboxy terminal type II procollagen peptide, chondroitin
sulfate isomers, tissue inhibitor of metalloproteinases in osteoarthritis
joint fluid. J Rheumatol 43(Suppl.):78-81, 1995 |
| 11 |
Alex Duarte, O.D., Ph.D.,
The Chicken Sternal Collagen Type II Cure (1997):82 |
* These statements have not been
evaluated by the Food and Drug Administration.
This product is not intended to diagnose, treat, cure, or prevent
any disease.
Disclaimer
|
|